Structural and Functional Validation of a Full-Thickness Self-Assembled Skin Equivalent for Disease Modeling

Recently, various types of in vitro-reconstructed 3D skin models have been developed for drug testing and disease modeling. Herein, we structurally and functionally validated a self-assembled reconstructed skin equivalent (RSE) and developed an IL-17a-induced in vitro psoriasis-like model using a se...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutics Vol. 14; no. 6; p. 1211
Main Authors Mok, Bo Ram, Shon, Su-Ji, Kim, A Ram, Simard-Bisson, Carolyne, Martel, Israël, Germain, Lucie, Kim, Dong Hyun, Shin, Jung U
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 07.06.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Recently, various types of in vitro-reconstructed 3D skin models have been developed for drug testing and disease modeling. Herein, we structurally and functionally validated a self-assembled reconstructed skin equivalent (RSE) and developed an IL-17a-induced in vitro psoriasis-like model using a self-assembled RSE. The tissue engineering approach was used to construct the self-assembled RSE. The dermal layer was generated using fibroblasts secreting their own ECM, and the epidermal layer was reconstructed by seeding keratinocytes on the dermal layer. To generate the psoriatic model, IL-17A was added to the culture medium during the air-liquid interface culture period. Self-assembled RSE resulted in a fully differentiated epidermal layer, a well-established basement membrane, and dermal collagen deposition. In addition, self-assembled RSE was tested for 20 reference chemicals according to the Performance Standard of OECD TG439 and showed overall sensitivity, specificity, and accuracy of 100%, 90%, and 95%, respectively. The IL-17a-treated psoriatic RSE model exhibited psoriatic epidermal characteristics, such as epidermal hyperproliferation, parakeratosis, and increased expression of KRT6, KRT17, hBD2, and S100A9. Thus, our results suggest that a self-assembled RSE that structurally and functionally mimics the human skin has a great potential for testing various drugs or cosmetic ingredients and modeling inflammatory skin diseases.
AbstractList Recently, various types of in vitro-reconstructed 3D skin models have been developed for drug testing and disease modeling. Herein, we structurally and functionally validated a self-assembled reconstructed skin equivalent (RSE) and developed an IL-17a-induced in vitro psoriasis-like model using a self-assembled RSE. The tissue engineering approach was used to construct the self-assembled RSE. The dermal layer was generated using fibroblasts secreting their own ECM, and the epidermal layer was reconstructed by seeding keratinocytes on the dermal layer. To generate the psoriatic model, IL-17A was added to the culture medium during the air–liquid interface culture period. Self-assembled RSE resulted in a fully differentiated epidermal layer, a well-established basement membrane, and dermal collagen deposition. In addition, self-assembled RSE was tested for 20 reference chemicals according to the Performance Standard of OECD TG439 and showed overall sensitivity, specificity, and accuracy of 100%, 90%, and 95%, respectively. The IL-17a-treated psoriatic RSE model exhibited psoriatic epidermal characteristics, such as epidermal hyperproliferation, parakeratosis, and increased expression of KRT6, KRT17, hBD2, and S100A9. Thus, our results suggest that a self-assembled RSE that structurally and functionally mimics the human skin has a great potential for testing various drugs or cosmetic ingredients and modeling inflammatory skin diseases.
Recently, various types of in vitro-reconstructed 3D skin models have been developed for drug testing and disease modeling. Herein, we structurally and functionally validated a self-assembled reconstructed skin equivalent (RSE) and developed an IL-17a-induced in vitro psoriasis-like model using a self-assembled RSE. The tissue engineering approach was used to construct the self-assembled RSE. The dermal layer was generated using fibroblasts secreting their own ECM, and the epidermal layer was reconstructed by seeding keratinocytes on the dermal layer. To generate the psoriatic model, IL-17A was added to the culture medium during the air-liquid interface culture period. Self-assembled RSE resulted in a fully differentiated epidermal layer, a well-established basement membrane, and dermal collagen deposition. In addition, self-assembled RSE was tested for 20 reference chemicals according to the Performance Standard of OECD TG439 and showed overall sensitivity, specificity, and accuracy of 100%, 90%, and 95%, respectively. The IL-17a-treated psoriatic RSE model exhibited psoriatic epidermal characteristics, such as epidermal hyperproliferation, parakeratosis, and increased expression of KRT6, KRT17, hBD2, and S100A9. Thus, our results suggest that a self-assembled RSE that structurally and functionally mimics the human skin has a great potential for testing various drugs or cosmetic ingredients and modeling inflammatory skin diseases.Recently, various types of in vitro-reconstructed 3D skin models have been developed for drug testing and disease modeling. Herein, we structurally and functionally validated a self-assembled reconstructed skin equivalent (RSE) and developed an IL-17a-induced in vitro psoriasis-like model using a self-assembled RSE. The tissue engineering approach was used to construct the self-assembled RSE. The dermal layer was generated using fibroblasts secreting their own ECM, and the epidermal layer was reconstructed by seeding keratinocytes on the dermal layer. To generate the psoriatic model, IL-17A was added to the culture medium during the air-liquid interface culture period. Self-assembled RSE resulted in a fully differentiated epidermal layer, a well-established basement membrane, and dermal collagen deposition. In addition, self-assembled RSE was tested for 20 reference chemicals according to the Performance Standard of OECD TG439 and showed overall sensitivity, specificity, and accuracy of 100%, 90%, and 95%, respectively. The IL-17a-treated psoriatic RSE model exhibited psoriatic epidermal characteristics, such as epidermal hyperproliferation, parakeratosis, and increased expression of KRT6, KRT17, hBD2, and S100A9. Thus, our results suggest that a self-assembled RSE that structurally and functionally mimics the human skin has a great potential for testing various drugs or cosmetic ingredients and modeling inflammatory skin diseases.
Author Simard-Bisson, Carolyne
Shin, Jung U
Kim, A Ram
Mok, Bo Ram
Shon, Su-Ji
Martel, Israël
Germain, Lucie
Kim, Dong Hyun
AuthorAffiliation 2 Centre de Recherche en Organogénèse Expérimentale de l’Université Laval/LOEX, and Department of Surgery, Faculty of Medicine, Université Laval, CHU de Québec-Université Laval Research Centre, Québec, QC G1J1Z4, Canada; carolyne.simard-bisson@crchudequebec.ulaval.ca (C.S.-B.); israel.martel@crchudequebec.ulaval.ca (I.M.); lucie.germain@fmed.ulaval.ca (L.G.)
1 Department of Biomedical Science, CHA University, Seongnam 13488, Korea; mokbbo@gmail.com (B.R.M.); orange11026@naver.com (S.-J.S.); tmfdkdjssl@hanmail.net (A.R.K.)
3 Department of Dermatology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13497, Korea; terios92@cha.ac.kr
AuthorAffiliation_xml – name: 1 Department of Biomedical Science, CHA University, Seongnam 13488, Korea; mokbbo@gmail.com (B.R.M.); orange11026@naver.com (S.-J.S.); tmfdkdjssl@hanmail.net (A.R.K.)
– name: 2 Centre de Recherche en Organogénèse Expérimentale de l’Université Laval/LOEX, and Department of Surgery, Faculty of Medicine, Université Laval, CHU de Québec-Université Laval Research Centre, Québec, QC G1J1Z4, Canada; carolyne.simard-bisson@crchudequebec.ulaval.ca (C.S.-B.); israel.martel@crchudequebec.ulaval.ca (I.M.); lucie.germain@fmed.ulaval.ca (L.G.)
– name: 3 Department of Dermatology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13497, Korea; terios92@cha.ac.kr
Author_xml – sequence: 1
  givenname: Bo Ram
  surname: Mok
  fullname: Mok, Bo Ram
  organization: Department of Biomedical Science, CHA University, Seongnam 13488, Korea
– sequence: 2
  givenname: Su-Ji
  surname: Shon
  fullname: Shon, Su-Ji
  organization: Department of Biomedical Science, CHA University, Seongnam 13488, Korea
– sequence: 3
  givenname: A Ram
  orcidid: 0000-0002-5458-1985
  surname: Kim
  fullname: Kim, A Ram
  organization: Department of Biomedical Science, CHA University, Seongnam 13488, Korea
– sequence: 4
  givenname: Carolyne
  surname: Simard-Bisson
  fullname: Simard-Bisson, Carolyne
  organization: Centre de Recherche en Organogénèse Expérimentale de l'Université Laval/LOEX, and Department of Surgery, Faculty of Medicine, Université Laval, CHU de Québec-Université Laval Research Centre, Québec, QC G1J1Z4, Canada
– sequence: 5
  givenname: Israël
  surname: Martel
  fullname: Martel, Israël
  organization: Centre de Recherche en Organogénèse Expérimentale de l'Université Laval/LOEX, and Department of Surgery, Faculty of Medicine, Université Laval, CHU de Québec-Université Laval Research Centre, Québec, QC G1J1Z4, Canada
– sequence: 6
  givenname: Lucie
  orcidid: 0000-0001-8883-6491
  surname: Germain
  fullname: Germain, Lucie
  organization: Centre de Recherche en Organogénèse Expérimentale de l'Université Laval/LOEX, and Department of Surgery, Faculty of Medicine, Université Laval, CHU de Québec-Université Laval Research Centre, Québec, QC G1J1Z4, Canada
– sequence: 7
  givenname: Dong Hyun
  surname: Kim
  fullname: Kim, Dong Hyun
  organization: Department of Dermatology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13497, Korea
– sequence: 8
  givenname: Jung U
  surname: Shin
  fullname: Shin, Jung U
  organization: Department of Dermatology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13497, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35745784$$D View this record in MEDLINE/PubMed
BookMark eNptUstuFDEQHKEgEkI-ATQSFy4Dfo99QYrygEhBHDZwtTx2z643Xntjz0Ti7_GyIUoQvtjtri53lft1cxBThKZ5i9FHShX6tF2ZvDEW5snbghkSmGD8ojnCSqmOKUIPnpwPm5NS1qguSrGk6lVzSHnPeC_ZURMWU57tNGcTWhNdezlHO_kUa_jTBO_MLmjT2JqaCqG7WXl7G6GUdgFh7E5Lgc0QwLWLWx_bi7vZ35sAcWrHlNtzX8AUaL8lB8HH5Zvm5WhCgZOH_bj5cXlxc_a1u_7-5ers9LqzHPGpgypnHGQVMBJMBuUwk8zJwY4UQAlGMbFSSDQSoRRi_cAp5oIgJ6UdiHH0uLna87pk1nqb_cbkXzoZr_9cpLzUJlfrAmhuhZMEceYEYaJXAwfCDVXCIWcJsMr1ec-1nYcNOFu1Va-ekT7PRL_Sy3Svq_MY96QSfHggyOluhjLpjS8WQjAR0lw0ERIjWp8WFfr-H-g6zbn-xQ7Vq14pIncd8T3K5lRKhvGxGYz0bjz0f8ej1r17quSx6u8w0N9ljbvE
CitedBy_id crossref_primary_10_3390_pharmaceutics14102085
crossref_primary_10_1016_j_intimp_2023_109945
crossref_primary_10_1002_btm2_10484
Cites_doi 10.1111/exd.12020
10.1111/exd.13531
10.1016/j.tiv.2014.02.014
10.1016/j.jdermsci.2008.07.009
10.3349/ymj.2021.62.11.969
10.1038/s41598-020-60275-0
10.1016/j.tiv.2018.02.007
10.1089/biores.2016.0036
10.1016/j.tiv.2017.03.010
10.1038/jid.2013.417
10.1016/j.jid.2019.06.145
10.1016/j.addr.2013.12.006
10.1089/ten.tea.2016.0529
10.1016/j.tiv.2021.105197
10.3390/ijms19010179
10.1073/pnas.78.7.4097
10.2217/rme-2016-0037
10.3390/jcm9113741
10.3390/biomedicines8110464
10.1111/vde.12655
10.22203/eCM.v036a10
10.1007/s12016-016-8535-x
10.1038/jid.2010.115
10.1089/ten.tea.2012.0117
10.1146/annurev-pathol-011811-132448
10.1016/B978-0-12-810545-0.00005-X
10.1016/j.ceb.2006.12.007
10.1038/nri2622
10.1111/j.1600-0536.1996.tb02175.x
10.1056/NEJMra0804595
10.1016/j.jid.2019.01.006
10.1159/000265681
10.1016/j.jid.2022.05.081
ContentType Journal Article
Copyright 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID NPM
AAYXX
CITATION
3V.
7XB
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
GNUQQ
GUQSH
M2O
MBDVC
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.3390/pharmaceutics14061211
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
ProQuest Central
ProQuest Central Student
Research Library Prep
ProQuest Research Library
Research Library (Corporate)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals - May need to register for free articles
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Research Library
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


CrossRef
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1999-4923
ExternalDocumentID oai_doaj_org_article_5c6d82054d624679b5e25a396d0dc2e4
10_3390_pharmaceutics14061211
35745784
Genre Journal Article
GeographicLocations United Kingdom--UK
United States--US
Japan
GeographicLocations_xml – name: United Kingdom--UK
– name: United States--US
– name: Japan
GrantInformation_xml – fundername: NIEHS NIH HHS
  grantid: 27304C0002
– fundername: South Korean government (MSIT) and the Ministry of Health & Welfare, Republic of Korea
  grantid: HR16C0002
– fundername: NIEHS NIH HHS
  grantid: 27306C0002
– fundername: National Research Foundation of Korea
  grantid: NRF-2020R1C1C1005293
– fundername: Ministry of Education of the Republic of Korea and the National Research Foundation of Korea
  grantid: NRF-2020R1C1C1005293
GroupedDBID ---
3V.
53G
5VS
8G5
AADQD
ABDBF
ABUWG
ACGFO
ACIHN
AEAQA
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BENPR
BPHCQ
CCPQU
DIK
DWQXO
EBD
ESX
F5P
FD6
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HH5
HYE
IAO
IHR
ITC
KQ8
M2O
M48
MK0
MODMG
M~E
NPM
OK1
P6G
PGMZT
PIMPY
PQQKQ
PROAC
RIG
RNS
RPM
TR2
TUS
AAYXX
CITATION
7XB
8FK
MBDVC
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c505t-e612fb8199f212b9d1484d8bcf3ee964312c8680f2699047b5315620d88cb2ad3
IEDL.DBID RPM
ISSN 1999-4923
IngestDate Fri Oct 04 13:17:50 EDT 2024
Tue Sep 17 21:25:22 EDT 2024
Sat Aug 17 04:44:07 EDT 2024
Thu Oct 10 16:22:29 EDT 2024
Thu Sep 26 21:02:52 EDT 2024
Sun Oct 13 09:30:08 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords psoriasis model
self-assembly tissue engineering
reconstructed skin
3D skin
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c505t-e612fb8199f212b9d1484d8bcf3ee964312c8680f2699047b5315620d88cb2ad3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-8883-6491
0000-0002-5458-1985
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231172/
PMID 35745784
PQID 2679799284
PQPubID 2032349
ParticipantIDs doaj_primary_oai_doaj_org_article_5c6d82054d624679b5e25a396d0dc2e4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9231172
proquest_miscellaneous_2681036796
proquest_journals_2679799284
crossref_primary_10_3390_pharmaceutics14061211
pubmed_primary_35745784
PublicationCentury 2000
PublicationDate 20220607
PublicationDateYYYYMMDD 2022-06-07
PublicationDate_xml – month: 6
  year: 2022
  text: 20220607
  day: 7
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Pharmaceutics
PublicationTitleAlternate Pharmaceutics
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Perera (ref_30) 2012; 7
Nestle (ref_31) 2009; 9
Mildner (ref_21) 2010; 130
Moon (ref_18) 2021; 62
Takami (ref_8) 2017; 23
ref_12
ref_34
Andrea (ref_14) 2018; 19
Steinert (ref_23) 1981; 78
Climov (ref_28) 2016; 4
Germain (ref_29) 2018; 36
Yaxiong (ref_15) 2016; 50
Ackermann (ref_5) 2010; 23
ref_17
Pouliot (ref_33) 2016; 11
Mathes (ref_2) 2014; 69–70
Jean (ref_32) 2009; 53
Shin (ref_36) 2020; 10
Niehues (ref_1) 2018; 27
Liao (ref_9) 2021; 75
Gu (ref_20) 2007; 19
Lavoie (ref_27) 2013; 19
ref_22
Jung (ref_4) 2014; 28
Nestle (ref_13) 2009; 361
Moos (ref_16) 2019; 139
York (ref_26) 1996; 34
Teramoto (ref_25) 2018; 29
ref_3
Pedrosa (ref_11) 2017; 42
Larouche (ref_19) 2016; 5
Kandarova (ref_10) 2018; 50
Bogaard (ref_35) 2014; 134
Malaisse (ref_6) 2012; 21
ref_7
Brewer (ref_24) 2020; 140
References_xml – ident: ref_7
– volume: 21
  start-page: 871
  year: 2012
  ident: ref_6
  article-title: Epidermal morphogenesis during progressive in vitro 3D reconstruction at the air-liquid interface
  publication-title: Exp. Dermatol.
  doi: 10.1111/exd.12020
  contributor:
    fullname: Malaisse
– volume: 27
  start-page: 501
  year: 2018
  ident: ref_1
  article-title: 3D skin models for 3R research: The potential of 3D reconstructed skin models to study skin barrier function
  publication-title: Exp. Dermatol.
  doi: 10.1111/exd.13531
  contributor:
    fullname: Niehues
– volume: 28
  start-page: 742
  year: 2014
  ident: ref_4
  article-title: KeraSkinTM-VM: A novel reconstructed human epidermis model for skin irritation tests
  publication-title: Toxicol. Vitr.
  doi: 10.1016/j.tiv.2014.02.014
  contributor:
    fullname: Jung
– volume: 53
  start-page: 19
  year: 2009
  ident: ref_32
  article-title: Development of an in vitro psoriatic skin model by tissue engineering
  publication-title: J. Dermatol. Sci.
  doi: 10.1016/j.jdermsci.2008.07.009
  contributor:
    fullname: Jean
– volume: 62
  start-page: 969
  year: 2021
  ident: ref_18
  article-title: In vitro models mimicking immune response in the skin
  publication-title: Yonsei Med. J.
  doi: 10.3349/ymj.2021.62.11.969
  contributor:
    fullname: Moon
– volume: 4
  start-page: e731
  year: 2016
  ident: ref_28
  article-title: Bioengineered self-assembled skin as an alternative to skin grafts
  publication-title: Plast. Reconstr. Surg.-Glob. Open
  contributor:
    fullname: Climov
– volume: 10
  start-page: 4123
  year: 2020
  ident: ref_36
  article-title: Recapitulating T cell infiltration in 3D psoriatic skin models for patient-specific drug testing
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-60275-0
  contributor:
    fullname: Shin
– volume: 50
  start-page: 407
  year: 2018
  ident: ref_10
  article-title: Pre-validation of an in vitro skin irritation test for medical devices using the reconstructed human tissue model EpiDermTM
  publication-title: Toxicol. Vitr.
  doi: 10.1016/j.tiv.2018.02.007
  contributor:
    fullname: Kandarova
– volume: 5
  start-page: 320
  year: 2016
  ident: ref_19
  article-title: Improved Methods to Produce Tissue-Engineered Skin Substitutes Suitable for the Permanent Closure of Full-Thickness Skin Injuries
  publication-title: Biores. Open Access
  doi: 10.1089/biores.2016.0036
  contributor:
    fullname: Larouche
– volume: 42
  start-page: 31
  year: 2017
  ident: ref_11
  article-title: A new reconstructed human epidermis for in vitro skin irritation testing
  publication-title: Toxicol. Vitr.
  doi: 10.1016/j.tiv.2017.03.010
  contributor:
    fullname: Pedrosa
– volume: 134
  start-page: 719
  year: 2014
  ident: ref_35
  article-title: Crosstalk between keratinocytes and T cells in a 3D microenvironment: A model to study inflammatory skin diseases
  publication-title: J. Investig. Dermatol.
  doi: 10.1038/jid.2013.417
  contributor:
    fullname: Bogaard
– volume: 140
  start-page: 361
  year: 2020
  ident: ref_24
  article-title: Peptides Derived from the Tight Junction Protein CLDN1 Disrupt the Skin Barrier and Promote Responsiveness to an Epicutaneous Vaccine
  publication-title: J. Investig. Dermatol.
  doi: 10.1016/j.jid.2019.06.145
  contributor:
    fullname: Brewer
– volume: 69–70
  start-page: 81
  year: 2014
  ident: ref_2
  article-title: The use of skin models in drug development
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2013.12.006
  contributor:
    fullname: Mathes
– volume: 23
  start-page: 481
  year: 2017
  ident: ref_8
  article-title: Construction of Three-Dimensional Dermo-Epidermal Skin Equivalents Using Cell Coating Technology and Their Utilization as Alternative Skin for Permeation Studies and Skin Irritation Tests
  publication-title: Tissue Eng.-Part A
  doi: 10.1089/ten.tea.2016.0529
  contributor:
    fullname: Takami
– volume: 75
  start-page: 105197
  year: 2021
  ident: ref_9
  article-title: Validation study of a new reconstructed human epidermis model EPiTRI for in vitro skin irritation test according to OECD guidelines
  publication-title: Toxicol. Vitr.
  doi: 10.1016/j.tiv.2021.105197
  contributor:
    fullname: Liao
– volume: 19
  start-page: 179
  year: 2018
  ident: ref_14
  article-title: Scanning the immunopathogenesis of psoriasis
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms19010179
  contributor:
    fullname: Andrea
– volume: 78
  start-page: 4097
  year: 1981
  ident: ref_23
  article-title: Characterization of a class of cationic proteins that specifically interact with intermediate filaments
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.78.7.4097
  contributor:
    fullname: Steinert
– volume: 11
  start-page: 545
  year: 2016
  ident: ref_33
  article-title: Tissue-engineered human psoriatic skin supplemented with cytokines as an in vitro model to study plaque psoriasis
  publication-title: Regen. Med.
  doi: 10.2217/rme-2016-0037
  contributor:
    fullname: Pouliot
– ident: ref_22
  doi: 10.3390/jcm9113741
– ident: ref_3
  doi: 10.3390/biomedicines8110464
– volume: 29
  start-page: 288-e98
  year: 2018
  ident: ref_25
  article-title: Expression of ZO-1 and claudin-1 in a 3D epidermal equivalent using canine progenitor epidermal keratinocytes
  publication-title: Vet. Dermatol.
  doi: 10.1111/vde.12655
  contributor:
    fullname: Teramoto
– volume: 36
  start-page: 128
  year: 2018
  ident: ref_29
  article-title: Autologous bilayered self-assembled skin substitutes (Sasss) as permanent grafts: A case series of 14 severely burned patients indicating clinical effectiveness
  publication-title: Eur. Cells Mater.
  doi: 10.22203/eCM.v036a10
  contributor:
    fullname: Germain
– volume: 50
  start-page: 377
  year: 2016
  ident: ref_15
  article-title: The Inflammatory Response in Psoriasis: A Comprehensive Review
  publication-title: Clin. Rev. Allergy Immunol.
  doi: 10.1007/s12016-016-8535-x
  contributor:
    fullname: Yaxiong
– volume: 130
  start-page: 2286
  year: 2010
  ident: ref_21
  article-title: Knockdown of filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model
  publication-title: J. Investig. Dermatol.
  doi: 10.1038/jid.2010.115
  contributor:
    fullname: Mildner
– volume: 19
  start-page: 1023
  year: 2013
  ident: ref_27
  article-title: Human epithelial stem cells persist within tissue-engineered skin produced by the self-assembly approach
  publication-title: Tissue Eng. (Part A)
  doi: 10.1089/ten.tea.2012.0117
  contributor:
    fullname: Lavoie
– volume: 7
  start-page: 385
  year: 2012
  ident: ref_30
  article-title: Psoriasis
  publication-title: Annu. Rev. Pathol. Mech. Dis.
  doi: 10.1146/annurev-pathol-011811-132448
  contributor:
    fullname: Perera
– ident: ref_34
  doi: 10.1016/B978-0-12-810545-0.00005-X
– ident: ref_17
– volume: 19
  start-page: 13
  year: 2007
  ident: ref_20
  article-title: Keratin function in skin epithelia: A broadening palette with surprising shades
  publication-title: Curr. Opin. Cell Biol.
  doi: 10.1016/j.ceb.2006.12.007
  contributor:
    fullname: Gu
– volume: 9
  start-page: 679
  year: 2009
  ident: ref_31
  article-title: Skin immune sentinels in health and disease
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2622
  contributor:
    fullname: Nestle
– volume: 34
  start-page: 204
  year: 1996
  ident: ref_26
  article-title: Evaluation of a human patch test for the identification and classification of skin irritation potential
  publication-title: Contact Dermat.
  doi: 10.1111/j.1600-0536.1996.tb02175.x
  contributor:
    fullname: York
– volume: 361
  start-page: 496
  year: 2009
  ident: ref_13
  article-title: Mechanisms of disease: Psoriasis
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra0804595
  contributor:
    fullname: Nestle
– volume: 139
  start-page: 1110
  year: 2019
  ident: ref_16
  article-title: Imiquimod-Induced Psoriasis in Mice Depends on the IL-17 Signaling of Keratinocytes
  publication-title: J. Investig. Dermatol.
  doi: 10.1016/j.jid.2019.01.006
  contributor:
    fullname: Moos
– volume: 23
  start-page: 105
  year: 2010
  ident: ref_5
  article-title: The phenion® full-thickness skin model for percutaneous absorption testing
  publication-title: Skin Pharmacol. Physiol.
  doi: 10.1159/000265681
  contributor:
    fullname: Ackermann
– ident: ref_12
  doi: 10.1016/j.jid.2022.05.081
SSID ssj0000331839
Score 2.3189058
Snippet Recently, various types of in vitro-reconstructed 3D skin models have been developed for drug testing and disease modeling. Herein, we structurally and...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1211
SubjectTerms 3D skin
Collagen
Digital cameras
Extracellular matrix
Fibroblasts
Medical research
Morphology
Psoriasis
psoriasis model
reconstructed skin
Scanning electron microscopy
self-assembly tissue engineering
Skin diseases
SummonAdditionalLinks – databaseName: Directory of Open Access Journals - May need to register for free articles
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYQp15QX9C0tJpKFSdS1k7iOMc-WKFKRUgsiFvkx1i76pKlWjjw7zsTL_tASFx6jR3FsWf8fePHN0J8CdKZElHnrDKZlzUFrMaEmCtl0dlonOrT-fw-1ScX5a-r6mot1RefCUvywKnjjiqvA6FUVQatyKkbV6GqbNHoMAheYVICldVaMNXPwQXbapOu7BQU1x_djFdLxHPJMKak3ACjXrP_KaL5-LzkGgANX4qdBXOEb6nFr8QWdq_FwVn64P0hjFY3qeaHcABnK1Hq-zdiet4LxbLIBtguwJDwLC0DwiVR8ZRZCWYRLHBUmo_GE_-Hp0E4x2nMeW_42k0xAGfrguO_dxMyUWooEOmFn2mXBzixGl9vfysuhsejHyf5ItNC7okB3eZIvREdkYMmEpS5JlCQVAbjfCwQWbFLKm-0GUSlCb3K2pHnEnEaBGO8UzYUu2K7m3X4TkDQrojWoDVEHKxFW5RROus1GiNR-0x8fejy9iYJarQUiPAYtU-OUSa-88AsK7Medv-ArKRdWEn7nJVkYv9hWNuFk85bRRXrpiGAzsTnZTG5F--Z2A5nd1zHSAL5utGZ2EtWsGxJUdUlTXj0dr1hHxtN3SzpJuNewptpNVHH9__j3z6IF4rvZPDSUL0vtsmc8CMxpVv3qXeKfwJhFOI
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdge-EFMT4DAxkJ7WlmjeM4zhNi0GpCYqpYh_YW-eO8VpSko9vD_vvdJWlL0cRrnCiW73z3uzv7d4x9CKkzCkALYpkUqsCA1ZgQhZQWnI3Gybadz_dTfXKuvl3kF33Cbdkfq1zZxNZQh8ZTjvxI6oIqUGhNPy2uBHWNoupq30LjIduVqaIy7e7x8HT8Y51lGWSks2V3dSfD-P5oMd2kipcpuTOZpltOqeXuvw9w_ntu8i9HNHrCHvcIkn_uRL7HHkD9lB2Mux_eHvLJ5kbV8pAf8PGGnPr2GZuftYSxRLbBbR34CP1alw7kPxGSdx2WeBO55RSdisl05n-ROeRnMI-CasS_3RwCp65dfHh1M0NVxYlyBL_8a1ft4dRgja65P2fno-Hky4noOy4Ij0joWgCuRnQIEsqILs2VAYMlFYzzMQMg5q5UeqPNIEqNXkwVDncwAqhBMMY7aUP2gu3UTQ2vGA_aZdEasAYBhLVgMxVTZ70GY1LQPmEfV0teLTpijQoDEpJRda-MEnZMglm_TLzY7YPmz2XVb7Mq9zogpslV0BJdQOlykLnNSh0GwUtQCdtfibXqN-uy2qhWwt6vh3GbUe3E1tDc0DsmRWdflDphLzstWM8kywuFhg-_Lrb0Y2uq2yP1bNpSeRO8Rgj5-v_TesMeSbp1QcmfYp_toKLAW8RC1-5dr_B3MOQOjA
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELem8cILAsZHxkBGQntaRuM4jv0wIRirJqShSWvR3iJ_nGlFl27rJq3_PXdJ2lJUHnhNnMTy3fl-58v9jrEPIXNaAqiUWCZTWWLAqnWIqRAWnI3aiaadz9l3dTqU3y6Lyy22IFToFnC2MbSjflLD28nhw838Exr8EUWcGLJ_vB6tTn9nGXkoQdW-j4TMJSn9WYf4m805JyU2Ta7ZUH81kbd1Pf9-05rHaoj9N6HRv3-q_MNL9Z-yJx285J9bfXjGtqB-zvbP2w_OD_hgVW41O-D7_HzFXD3fYZOLhk2WmDi4rQPvo9Nrzwr5D8TrbfslPo3ccgpd08Fo7H_RXskvYBJTSiBfuQkETi29-MnN_Rj1GCfKERnzr20qiFP3NaqBf8GG_ZPB8WnatWNIPcKkuxRwNaJDBGEi-jtnAkZSMmjnYw5AtF6Z8FrpXhQKXZwsHZo3oqte0No7YUP-km3X0xpeMx6Uy6PVYDWiC2vB5jJmznoFWmegfMIOF0teXbesGxVGKySjaqOMEvaFBLMcTKTZzYXp7c-qs8Gq8Cog4ClkUAL9g3EFiMLmRoVe8AJkwvYWYq0WilgJHFgag148Ye-Xt9EGKbFia5je0xidIRIojUrYq1YLljPJi1LirohPl2v6sTbV9Tv1eNTwfBP2Rny5-7-L8YY9FlSkQWdF5R7bRtWBtwid7ty7xhh-A7z4G7g
  priority: 102
  providerName: Scholars Portal
Title Structural and Functional Validation of a Full-Thickness Self-Assembled Skin Equivalent for Disease Modeling
URI https://www.ncbi.nlm.nih.gov/pubmed/35745784
https://www.proquest.com/docview/2679799284
https://www.proquest.com/docview/2681036796/abstract/
https://pubmed.ncbi.nlm.nih.gov/PMC9231172
https://doaj.org/article/5c6d82054d624679b5e25a396d0dc2e4
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PT9swFH4CJk1cpv1eNlZ50sSJtI3jOM5xsFZoUlE1ysQt8s-1WpsWCgf--z07SUsnTrvk0LiKFX_O9z3b73sAX02iBLOWx95lMmY5BqxCGBdTKq2STigayvmMLvj5FftxnV3vQdbmwoRD-1rNutV80a1m03C2crXQvfacWG88OvOiBIm3tw_7eZo-CtHD5zf1MC3qbJ0UQ_rearpdHV4nnsEw6jmE52mWMwQs26Gk4Nz_lNz899TkIxoavoQXjX4k3-p-voI9W72G43H97IcTMtnmU61PyDEZb62pH97A_DLYxXqrDSIrQ4bIavViIPmFgryur0SWjkjiY9N4Mp3pP_5jSC7t3MV-h3ih5tYQX7OLDG7uZwhU7ChB6Uu-13s9xJdX80nub-FqOJicncdNvYVYow66iy2-GKdQIhQOCU0VBkMlZoTSLrXW-3YlVAsu-o5y5DCWK5y_KJ_6RgitqDTpOziolpX9AMRwlToprBQoH6S0MmUuUVJzK0RiuY6g277yclXbapQYjvjhKp8crghO_cBsGntX7PDD8vZ32WCjzDQ3qGgyZjhFAihUZmkm04KbvtHUsgiO2mEtm6m6Lik2zIsCaTqCL5vbOMn8zoms7PLetxEJUn1e8Aje1yjY9KRFUQT5Dj52urp7B3EdjLwbHH_8739-gkPq0zH8qlB-BAeIIfsZRdKd6sCz08HF-GcnLDLgdcREJ0yUv8XgGV0
link.rule.ids 230,315,733,786,790,870,891,2115,2236,21416,24346,27955,27956,33777,33778,43838,53825,53827,74657
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEB5BeoBLVd5uCywS6qmm8dper0-IQqIAbRTRFPVm7ZNETe2UtIf-e2ZsJyGo4uq15dXO7Mw3M7vfALy3kZaJcyIklskwyTBgldL6kHPltPJS87qdz-lQDM6TbxfpRZtwW7THKpc2sTbUtjKUIz_iIqMKFFrTj_PrkLpGUXW1baHxELaIclN2YOu4Nxz9WGVZujHpbN5c3Ykxvj-aT9ap4kVE7oxH0YZTqrn77wOc_56b_MsR9Xdgu0WQ7FMj8ifwwJVP4WDU_PDukI3XN6oWh-yAjdbk1HfPYHZWE8YS2QZTpWV99GtNOpD9REjedFhilWeKUXQajidTc0nmkJ25mQ-pRnylZ84y6trFete3U1RVnChD8Mu-NNUeRg3W6Jr7czjv98afB2HbcSE0iIRuQoer4TWChNyjS9O5xWApsVIbHztHzF0RN1LIrucCvViSadzBCKC6VkqjubLxC-iUVeleAbNCx15JpyQCCKWcihMfaWWEkzJywgTwYbnkxbwh1igwICEZFffKKIBjEszqZeLFrh9Uv38V7TYrUiMsYpo0sYKjC8h16niq4lzYrjXcJQHsL8VatJt1UaxVK4B3q2HcZlQ7UaWrbukdGaGzz3IRwMtGC1YzidMsQcOHX2cb-rEx1c2RcjqpqbwJXiOE3P3_tN7Co8H49KQ4-Tr8vgePOd3AoERQtg8dVBr3GnHRjX7TKv8fIwkRgg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgkxAviO8FBhgJ7WmmjeM4zhNirNX4qirWob1F_qQVJeno9rD_nrvEbSmaeI0TxfKd7353Z_-OkDcuNUp4LxmyTDJRQMCqlAuMc-2NDsrwtp3P15E8OROfzvPzeP5pGY9Vrmxia6hdYzFH3uOywAoUWNNeiMcixsfDd4sLhh2ksNIa22ncJruFkDkEYrtHg9H42zrj0s9Qf8vuGk8GsX5vMd2kjZcpujaeplsOquXxvwl8_nuG8i-nNLxP7kU0Sd934n9Abvn6ITkYdz-8PqSTze2q5SE9oOMNUfX1IzI_bcljkXiD6trRIfi4LjVIvwM877ot0SZQTTFSZZPpzP5E00hP_TwwrBf_MnPvKHbwooOLqxmoLUyUAhCmx13lh2KzNbzy_picDQeTDycsdl9gFlDRJfOwGsEAYCgDuDdTOgichFPGhsx7ZPFKuVVS9QOX4NFEYWA3A5jqO6Ws4dplT8hO3dR-j1AnTRa08loBmNDa60yE1GgrvVKplzYhb1dLXi06ko0KghOUUXWjjBJyhIJZv4wc2e2D5vePKm65KrfSAb7JhZMc3EFpcs9znZXS9Z3lXiRkfyXWKm7cZbVRs4S8Xg_DlsM6iq59c4XvqBQcf1HKhDzttGA9kywvBBhB-LrY0o-tqW6P1LNpS-uNUBvg5LP_T-sVuQN6X335OPr8nNzleBkDc0LFPtkBnfEvACJdmpdR9_8As5AVtg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structural+and+Functional+Validation+of+a+Full-Thickness+Self-Assembled+Skin+Equivalent+for+Disease+Modeling&rft.jtitle=Pharmaceutics&rft.au=Mok%2C+Bo+Ram&rft.au=Shon%2C+Su-Ji&rft.au=Kim%2C+A+Ram&rft.au=Simard-Bisson%2C+Carolyne&rft.date=2022-06-07&rft.issn=1999-4923&rft.eissn=1999-4923&rft.volume=14&rft.issue=6&rft.spage=1211&rft_id=info:doi/10.3390%2Fpharmaceutics14061211&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_pharmaceutics14061211
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1999-4923&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1999-4923&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1999-4923&client=summon